Sodium Ascorbate, Cholecalciferol, Di-Alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hcl, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (Ii) Bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, With Doconexent And Icosapent
Prescription商品名: NESTABS DHA Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA
About This Medication
D escripton: Nestabs DHA combination tablet-capsule for oral administration is a light pink capsule-shaped film coated tablet with a pleasant sweet flavor with WCOO1 imprinted on one side of the tablet and a enteric coated light amber soft gel capsule omega-3 fatty acid containing both DHA and EPA.
適応症と用法
用量と投与方法
Side Effects Overview
警告と注意事項
W arnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
禁忌
C ontraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients .
Frequently Asked Questions
I ndications and Usage: Nestabs DHA is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. Nestabs DHA is also beneficial in improving the nutritional status of women prior to conception.
D osage and Administration: Nestabs DHA - One tablet and one soft gel capsule daily or as directed by a physician.
W arnings: Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
C ontraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients .
Sodium Ascorbate, Cholecalciferol, Di-Alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hcl, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (Ii) Bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, With Doconexent And Icosapent is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Other Products
Browse all Other products →References & Data Sources
- • DailyMed — Sodium Ascorbate, Cholecalciferol, Di-Alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hcl, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (Ii) Bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, With Doconexent And Icosapent drug label (National Library of Medicine)
- • openFDA — Sodium Ascorbate, Cholecalciferol, Di-Alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hcl, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (Ii) Bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, With Doconexent And Icosapent label data (U.S. Food & Drug Administration)
- • NDC Directory — Sodium Ascorbate, Cholecalciferol, Di-Alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hcl, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (Ii) Bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, Choline Bitartrate, With Doconexent And Icosapent (FDA National Drug Code)
医療免責事項
このページの情報は教育目的のみを意図しており、専門家による医療アドバイス、診断、または治療の代替として使用すべきではありません。
疾患や医薬品に関するご質問がある場合は、必ず担当医またはその他の資格を持つ医療専門家にご相談ください。
データソース: DailyMed (NLM), openFDA, MFDS